WallStSmart

M-tron Industries, Inc. (MPTI)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 376% more annual revenue ($258.90M vs $54.42M). MPTI leads profitability with a 15.5% profit margin vs -15.5%. MPTI earns a higher WallStSmart Score of 64/100 (C+).

MPTI

Buy

64

out of 100

Grade: C+

Growth: 8.0Profit: 8.5Value: 6.0Quality: 8.5
Piotroski: 2/9Altman Z: 7.26

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

MPTIUndervalued (+9.8%)

Margin of Safety

+9.8%

Fair Value

$70.64

Current Price

$66.78

$3.86 discount

UndervaluedFair: $70.64Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MPTI4 strengths · Avg: 9.0/10
Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
7.2610/10

Safe zone — low bankruptcy risk

Operating MarginProfitability
27.3%8/10

Strong operational efficiency at 27.3%

EPS GrowthGrowth
35.7%8/10

Earnings expanding 35.7% YoY

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

MPTI2 concerns · Avg: 3.0/10
Market CapQuality
$228.84M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : MPTI

The strongest argument for MPTI centers on Debt/Equity, Altman Z-Score, Operating Margin. Profitability is solid with margins at 15.5% and operating margin at 27.3%. Revenue growth of 11.2% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : MPTI

The primary concerns for MPTI are Market Cap, Piotroski F-Score.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

MPTI profiles as a mature stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor ELECTRONIC COMPONENTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

MPTI scores higher overall (64/100 vs 41/100), backed by strong 15.5% margins and 11.2% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

M-tron Industries, Inc.

TECHNOLOGY · ELECTRONIC COMPONENTS · USA

M-tron Industries, Inc. designs, manufactures and markets frequency and spectrum control products. The company is headquartered in Orlando, Florida.

Visit Website →

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?